MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves
暂无分享,去创建一个
[1] H. Dingle,et al. Patterns of recreational drug use at dance events in Edinburgh, Scotland. , 2001, Addiction.
[2] R. Dafters. Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing , 1995, Physiology & Behavior.
[3] M. Bourin,et al. 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans , 1999, Neuroscience & Biobehavioral Reviews.
[4] J A Gunn,et al. The action of some amines related to adrenaline. Cyclohexylalkylamines , 1940, The Journal of physiology.
[5] A. Blokland,et al. Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes , 2003, Psychopharmacology.
[6] J. O'Callaghan,et al. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat , 1991, Pharmacology Biochemistry and Behavior.
[7] T. Ernst,et al. Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users , 1999, Journal of magnetic resonance imaging : JMRI.
[8] A. Parrott,et al. Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity , 2002, Pharmacology Biochemistry and Behavior.
[9] P. Tossmann,et al. The Use of Drugs within the Techno Party Scene in European Metropolitan Cities , 2001, European Addiction Research.
[10] A. Parrott,et al. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug , 2001, Journal of psychopharmacology.
[11] G. D. den Heeten,et al. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results. , 2002, AJNR. American journal of neuroradiology.
[12] U. McCann,et al. (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals , 2000, Neuropsychobiology.
[13] V. Sánchez,et al. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (‘binge’ ingestion) low dose of MDMA , 2004, Psychopharmacology.
[14] M. Spitzer,et al. Psychological Effects of MDE in Normal Subjects , 1993, Neuropsychopharmacology.
[15] A. Morton,et al. Methamphetamine toxicity in mice is potentiated by exposure to loud music , 2001, Neuroreport.
[16] A. Scholey,et al. Understanding Drugs and Behaviour , 2004 .
[17] N. Solowij,et al. Ecstasy use in Australia: patterns of use and associated harm. , 1999, Drug and alcohol dependence.
[18] Z. Szabo,et al. Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings , 1998, The Lancet.
[19] T. Buchanan,et al. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users , 2002, Human psychopharmacology.
[20] D E Nichols,et al. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. , 1998, Neurotoxicology.
[21] I. McGregor,et al. Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. , 2003, European journal of pharmacology.
[22] B. Sahakian,et al. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users , 2002, Psychopharmacology.
[23] A. Winstock,et al. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. , 2001, Drug and alcohol dependence.
[24] A. Parrott,et al. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. , 2000, Drug and alcohol dependence.
[25] W. van den Brink,et al. Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach , 2001, Human psychopharmacology.
[26] E. Rüther,et al. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) and its congeners , 2005, Journal of Neural Transmission.
[27] F. Schifano. Potential Human Neurotoxicity of MDMA (‘Ecstasy’): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies , 2000, Neuropsychobiology.
[28] J. Strang,et al. Understanding reasons for drug use amongst young people: a functional perspective. , 2001, Health education research.
[29] M. Morgan,et al. Ecstasy (MDMA): a review of its possible persistent psychological effects , 2000, Psychopharmacology.
[30] A. B. Scholey,et al. Differential effects of Ecstasy and cannabis on self‐reports of memory ability: a web‐based study , 2001, Human psychopharmacology.
[31] S. Dawling,et al. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") , 1992, The Lancet.
[32] A. Parrott. Human Research on MDMA (3,4-Methylene- dioxymethamphetamine) Neurotoxicity: Cognitive and Behavioural Indices of Change , 2000, Neuropsychobiology.
[33] Andrew C. Parrott,et al. Ecstasy (MDMA) in Recreational Users: Self‐Reported Psychological and Physiological Effects , 1997 .
[34] M. Colado,et al. The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) , 2003, Pharmacological Reviews.
[35] M. Colado,et al. A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation , 2001, Psychopharmacology.
[36] J. V. van Gerven,et al. Cognitive performance and serotonergic function in users of ecstasy , 2000, Psychopharmacology.
[37] H. Pope,et al. Drug use and life style among college undergraduates: a 30-year longitudinal study. , 2001, The American journal of psychiatry.
[38] G. Goodwin,et al. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) , 1995, Psychopharmacology.
[39] N. Solowij,et al. Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects , 2004, Journal of psychopharmacology.
[40] L. Seiden,et al. Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat , 1998, The Journal of Neuroscience.
[41] L. Seiden,et al. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. , 1985, Science.
[42] L. Baute,et al. Emergency medical assistance during a mass gathering. , 1999, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[43] A. Parrott. Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research , 2001, Human psychopharmacology.
[44] P. Skudlarski,et al. Preliminary evidence of hippocampal dysfunction in adolescent MDMA (“ecstasy”) users: possible relationship to neurotoxic effects , 2004, Psychopharmacology.
[45] T. Ullrich,et al. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice , 2003, Psychopharmacology.
[46] B. Stimmel,et al. The Love Drug: Marching to the Beat of Ecstasy , 1998 .
[47] B. Maycock,et al. ‘Weddings, parties, anything…’, a qualitative analysis of ecstasy use in Perth, Western Australia , 2001 .
[48] A. Scholey,et al. Patterns of Drug Use and the Influence of Gender on Self-Reports of Memory Ability in Ecstasy Users: A Web-Based Study , 2003, Journal of psychopharmacology.
[49] C. J. Schmidt,et al. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.
[50] F. Vollenweider,et al. Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies , 2001, Human psychopharmacology.
[51] R. Dafters,et al. Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) but not by fenfluramine , 1998, Psychopharmacology.
[52] M. Colado,et al. Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function , 2004, Psychopharmacology.
[53] M. Thiébot,et al. Behavioral Effects of Cannabinoid Agents in Animals. , 1999, Critical reviews in neurobiology.
[54] U. McCann,et al. (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies , 2000, Neuropsychobiology.